Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mollejo

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 4, 1998
Absence of cyclin D1 protein expression in splenic marginal zone lymphomaE Savilo, E Campo, M Mollejo, et al.
Anales Espanoles De Pediatria|April 1, 1991
[Celiac disease and glycogenosis]J M Moreno Villares, C Gutiérrez Junquera, M L García García, et al.
The American Journal of Pathology|May 5, 2001
Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogeneticsJ M Hernández, J L García, N C Gutiérrez, et al.
British Journal of Cancer|July 29, 1999
p27KIP1 is abnormally expressed in Diffuse Large B-cell Lymphomas and is associated with an adverse clinical outcomeA Sáez, E Sánchez, M Sánchez-Beato, et al.
Cell Death and Differentiation|January 15, 2011
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral actionM Lorente, S Torres, M Salazar, et al.
Blood Cancer Journal|July 26, 2012
MicroRNA signatures in B-cell lymphomasL Di Lisio, M Sánchez-Beato, G Gómez-López, et al.
Leukemia|July 27, 2011
Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphomaD Martín-Pérez, P Vargiu, S Montes-Moreno, et al.
Haematologica|January 9, 2001
Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7qF Solé, M Salido, B Espinet, et al.
Leukemia|May 29, 2009
Identification of MNDA as a new marker for nodal marginal zone lymphomaG Kanellis, G Roncador, A Arribas, et al.
Leukemia|February 16, 2016
Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemiaI Alvarez-Twose, P Martínez-Barranco, J Gotlib, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 4, 1998
Absence of cyclin D1 protein expression in splenic marginal zone lymphomaE Savilo, E Campo, M Mollejo, et al.
Anales Espanoles De Pediatria|April 1, 1991
[Celiac disease and glycogenosis]J M Moreno Villares, C Gutiérrez Junquera, M L García García, et al.
The American Journal of Pathology|May 5, 2001
Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogeneticsJ M Hernández, J L García, N C Gutiérrez, et al.
British Journal of Cancer|July 29, 1999
p27KIP1 is abnormally expressed in Diffuse Large B-cell Lymphomas and is associated with an adverse clinical outcomeA Sáez, E Sánchez, M Sánchez-Beato, et al.
Cell Death and Differentiation|January 15, 2011
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral actionM Lorente, S Torres, M Salazar, et al.
Blood Cancer Journal|July 26, 2012
MicroRNA signatures in B-cell lymphomasL Di Lisio, M Sánchez-Beato, G Gómez-López, et al.
Leukemia|July 27, 2011
Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphomaD Martín-Pérez, P Vargiu, S Montes-Moreno, et al.
Haematologica|January 9, 2001
Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7qF Solé, M Salido, B Espinet, et al.
Leukemia|May 29, 2009
Identification of MNDA as a new marker for nodal marginal zone lymphomaG Kanellis, G Roncador, A Arribas, et al.
Leukemia|February 16, 2016
Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemiaI Alvarez-Twose, P Martínez-Barranco, J Gotlib, et al.
Pageof 6